World Mental Health Day 2024: Use art and music therapy to boost emotional well-being of senior citizens
Art and music therapy are powerful tools in geriatric care, bridging the gap between physical health and emotional well-being ...
5 Halloween walks and activities in London’s most haunted borough
Kensington and Chelsea is home to some of the city’s most extravagant houses, and things get even more enticing around ...
Altoona Mirror8d
The best medicine: PawZone therapy dogs spread joy during visits to schools, nursing homes
Tails wag and smiles and laughter abound when PawZone therapy dogs arrive at Garvey Manor Nursing Home. Visitors and staff ...
The American Journal of Managed Care4d
Muscle-Directed Therapy Apitegromab Meets Primary End Point in Phase 3 SAPPHIRE Trial of SMA
Patients aged 2-21 receiving apitegromab showed clinically meaningful motor function improvements, with a favorable safety ...
Science Daily4d
For multiple sclerosis, medication and cognitive behavioral therapy can reduce fatigue
In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...
Medication and cognitive behavioral therapy can reduce fatigue among MS patients, finds study
In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a ...
Business Wire2d
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapav…
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Joplin Globe10d
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors ...
Pharmabiz5d
US FDA accepts for priority review GSK’s NDA for gepotidacin to treat uncomplicated urinary tract infections in female adults and adolescents
US FDA accepts for priority review GSK’s NDA for gepotidacin to treat uncomplicated urinary tract infections in female adults and adolescents: London, UK Thursday, October 17, 2 ...
Getaway Magazine5d
Wild therapy in the Waterberg
Can losing yourself in an expansive landscape inhabited by a rich diversity of wildlife allow you to regain yourself? Ryan ...
Pharmabiz8d
Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors
Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST] Pfizer ...
Zacks.com on MSN13d
RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy Tag
Ultragenyx announces that the FDA grants Breakthrough Therapy designation to its investigational osteogenesis imperfecta treatment candidate, setrusumab.